[go: up one dir, main page]

GB910427A - Aza-bicycloalkyl-(n)-alkylguanidine compounds and process for their manufacture - Google Patents

Aza-bicycloalkyl-(n)-alkylguanidine compounds and process for their manufacture

Info

Publication number
GB910427A
GB910427A GB3872560A GB3872560A GB910427A GB 910427 A GB910427 A GB 910427A GB 3872560 A GB3872560 A GB 3872560A GB 3872560 A GB3872560 A GB 3872560A GB 910427 A GB910427 A GB 910427A
Authority
GB
United Kingdom
Prior art keywords
bicycloalkyl
numbers
general formula
aza
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3872560A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB910427A publication Critical patent/GB910427A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention comprises aza-bicycloalkyl-(N)-alkylguanidines of the general formula: <FORM:0910427/IV (b)/1> and their acyl derivatives, quaternary ammonium compounds and acid addition salts (including ascorbates), in which A stands for a 1-5 membered hydrocarbon chain which may also contain a double bond or be interrupted by a nitrogen atom which may be unsubstituted or substituted by an alkyl or aralkyl group, m represents any one of the numbers from 0 to 6, m1 any one of the numbers from 1 to 7, n and n1 any one of the numbers from 0 to 3. R and R1 stand for hydrogen atoms or C1-7-alkyl groups and G for a guanido group, with the proviso that CmH2m separates the bridgehead atoms by at most 2 carbon atoms, and in which <FORM:0910427/IV (b)/2> when A forms a 3-5 membered isocyclic ring with the bridge members and <FORM:0910427/IV (b)/3> when A forms a 4-membered azacyclic ring with the bridge members, and the preparation thereof by reacting an aza - bicycloalkyl - (N) - alkylamine corresponding to the above general formula but wherein G represents a primary or secondary amino group with S-methylthiourea or a mineral acid addition salt thereof. Acyl derivatives may be prepared from mono or dicarboxylic acids or sulphonic acids which may contain further substituents. Quaternary ammonium salts are preferably prepared from esters of lower alkanols or aralkanols. The guanidines of the above general formula are useful as antihypertensive agents, and pharmaceutical compositions comprise the said compounds in admixture or in conjunction with an inert carrier suitable for enteral or parenteral administration. The compositions may contain other therapeutically useful substances, and may be in the form of tablets, dragees, capsules, solutions, suspensions or emulsions. Specification 910,428 is referred to.
GB3872560A 1959-11-10 1960-11-10 Aza-bicycloalkyl-(n)-alkylguanidine compounds and process for their manufacture Expired GB910427A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85197059A 1959-11-10 1959-11-10
US5459360A 1960-09-08 1960-09-08

Publications (1)

Publication Number Publication Date
GB910427A true GB910427A (en) 1962-11-14

Family

ID=26733241

Family Applications (2)

Application Number Title Priority Date Filing Date
GB3872560A Expired GB910427A (en) 1959-11-10 1960-11-10 Aza-bicycloalkyl-(n)-alkylguanidine compounds and process for their manufacture
GB1108862A Expired GB910428A (en) 1959-11-10 1960-11-10 Aza-bicycloalkyl-(n)-alkylamine compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1108862A Expired GB910428A (en) 1959-11-10 1960-11-10 Aza-bicycloalkyl-(n)-alkylamine compounds

Country Status (5)

Country Link
BR (1) BR6024099D0 (en)
CH (1) CH408009A (en)
DE (1) DE1421000A1 (en)
GB (2) GB910427A (en)
NL (1) NL133063C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3516989A (en) * 1967-10-02 1970-06-23 American Home Prod Intermediates for total synthesis of iboga alkaloids and means of preparation

Also Published As

Publication number Publication date
BR6024099D0 (en) 1973-06-12
NL133063C (en)
GB910428A (en) 1962-11-14
DE1421000A1 (en) 1968-10-24
CH408009A (en) 1966-02-28

Similar Documents

Publication Publication Date Title
GB970886A (en) New pyridines and process for the manufacture thereof
GB1254332A (en) Amino acids and their derivatives and processes for preparing them
GB989013A (en) New guanidines and process for their manufacture
GB937723A (en) Pyrazolo-pyrimidines and process for their manufacture
US3050525A (en) Certain derivatives of s-triazolo [4, 3-a]-pyridine
GB1016071A (en) New guanidine derivatives and process for preparing the same
GB910427A (en) Aza-bicycloalkyl-(n)-alkylguanidine compounds and process for their manufacture
GB1084150A (en)
GB1383888A (en) Amino ether derivatives of orthothymatic esters
GB1008470A (en) New cyanacetamide derivatives
GB1207930A (en) Azacycloaliphatic compounds, process for their manufacture and compositions containing them
GB1144935A (en) Anthrol derivatives and the preparation thereof
GB1061946A (en) Novel dibenzocycloheptene derivatives and a process for the manufacture thereof
GB1177722A (en) Substituted Glucofuranosides, Process for their Manufacture and Compositions Containing Same
US2828315A (en) Procaine salt of pyridoxal phosphate and process
GB1441873A (en) Diamino-benzophenones
GB1193534A (en) Novel Benzazocine Derivatives, the Preparation thereof and Compositions Containing the same
GB927288A (en) 1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them
GB1323453A (en) Substituted oximes processes for their production and pharmaceutical compositions
US3644417A (en) Coronary vasodilator compounds
GB920859A (en) Substituted triphenylmethanols
GB1199857A (en) o-Substituted 2-Phenylimino-1-Azacycloheptanes and their production
GB1254142A (en) Process for the manufacture of new thiopyranothieno-pyrimidine derivatives
GB982945A (en) Phenylalanine derivatives
GB952891A (en) Guanidino compounds and method of producing the same